RIABNI
RIABNI
Discontinued
DIN Number
02513447
Drug Class
Human
Market Date
Apr 21, 2021
Company
HC
Amgen Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02513447
AIG Number0140241001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FA01 RITUXIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
RITUXIMABActive
Strength: 10 MG / ML
Monograph: RITUXIMAB